Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer

Grant

Date/time Interval

  • January 1, 2020 - December 31, 2024

    • Awarded By

    Total Award Amount

  • 475483.00

    • Direct Costs

  • 324000.00

    • Sponsor Award Id

  • R01CA238273

    • Contributor

  • Erica Stringer-Reasor M.D.   Investigator  
  • Jianmei Leavenworth Ph.D.   Investigator  
  • Runhua Liu M.D., Ph.D.   Principal Investigator  
  • Sejong Bae Ph.D.   Investigator  
  • Shi Wei M.D., Ph.D.   Investigator  
  • Xiaoguang Liu   Investigator